markets · · 247wallst.com

Can Specialty Meds Offset GSK's $2.2B Legal Charges and Sizzling R&D Setbacks on Oct. 28?

GSK (NYSE:GSK | GSK Price Prediction) reports third-quarter results on October 28. A $2.

Can Specialty Meds Offset GSK's $2.2B Legal Charges and Sizzling R&D Setbacks on Oct. 28?

GSK (NYSE:GSK | GSK Price Prediction) reports third-quarter results on October 28. A $2.

  • #GSK